Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons

HIV Medicine

Volumn 17, Issue 2, 2016, Pages 83-88

  Ryom, L ^a   Boesecke, Christoph ⁱ   Gisler, Valentin ⁱ   Manzardo, Christian ⁱ   Rockstroh, J K ^b   Puoti, Massimo ⁱ   Furrer, Hansjakob ⁱ   Miro, Jose M ⁱ   Gatell, J M ^d   Pozniak, A ^f   Behrens, Georg ⁱ   Battegay, M ^h   Lundgren, J D ^a   Monforte, Antonella d'Arminio ⁱ   Arribas, José ⁱ   Clumeck, Nathan ⁱ   Dedes, Nikos ⁱ   Geretti, Anna Maria ⁱ   Horban, Andrzej ⁱ   Katlama, Christine ⁱ   McCormack, Sheena ⁱ   Molina, Jean Michel ⁱ   Mussini, Cristina ⁱ   Raffi, François ⁱ   Reiss, Peter ⁱ   Stellbrink, Hans Jürgen ⁱ   Bower, Mark ⁱ   Cinque, Paola ⁱ   Collins, Simon ⁱ   Compston, Juliet ⁱ   Deray, Gilbert ⁱ   De Wit, Stéphane ⁱ   Fux, Christoph A ⁱ   Guraldi, Giovanni ⁱ   Mallon, Patrick ⁱ   Martinez, Esteban ⁱ   Marzolini, Catia ⁱ   Papapoulos, Socrates ⁱ   du Pasquier, Renaud ⁱ   Poulter, Neil ⁱ   Williams, Ian ⁱ   Winston, Alan ⁱ   Bhagani, Sanjay ⁱ   Bruno, Raffaele ⁱ   Konov, Svilen ⁱ   Lacombe, Karine ⁱ   Mauss, Stefan ⁱ   Mendao, Luis ⁱ   Peters, Lars ⁱ   Rauch, Andri ⁱ   Tural, Cristina ⁱ   Fätkenheuer, Gerd ⁱ   Kirk, Ole ⁱ   Mocroft, Amanda ⁱ   Morlat, Philippe ⁱ   Volny Anne, Alain ⁱ   Mulcahy, Fiona ⁱ   Oprea, Cristiana ⁱ   Youle, Mike ⁱ   more..

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF BARCELONA   (Spain)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ NONE

Author keywords

Antiretroviral treatment; ART; Comorbidities; EACS; Guidelines; HBV; HCV; HIV; Opportunistic infections

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; COMORBIDITY; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL SOCIETY; MIXED INFECTION; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DRUG INTERACTION; EUROPE; FEMALE; HEALTH CARE QUALITY; HIV INFECTIONS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; POST EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DRUG INTERACTIONS; EUROPE; FEMALE; GUIDELINES AS TOPIC; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; POST-EXPOSURE PROPHYLAXIS; PRE-EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOCIETIES, MEDICAL; STANDARD OF CARE; VIRAL LOAD;

EID: 84956904407     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12322     Document Type: Article

References (4)

1. www.eacssociety.org.
2. The European Aids Clinical Society Bienial Report 2015.
3. EACS guidelines v.8.0 http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html.
4. NIH Starting Antiretroviral Treatment Early improves Outcomes for HIV-infected individuals. Available at: http://www.niaid.nih.gov/news/newsreleases/2015/Pages/START.aspx#.